Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Liver Neoplasms × Positron-Emission Tomography × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 7 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Leukemia 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Esophageal Neoplasms 2 Central Nervous System Neoplasms 2 Burkitt Lymphoma 2 Brain Neoplasms 2 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Smoking Cessation 1 Sezary Syndrome 1 Pulmonary Fibrosis 1

Interventions

durvalumab 11 Bevacizumab 11 Nivolumab 8 pembrolizumab 7 tremelimumab 6 lenvatinib 6 fludarabine 6 Cyclophosphamide 6 atezolizumab 5 Sorafenib 4 Radiosurgery 4 Cisplatin 4 toripalimab 3 regorafenib 3 Ipilimumab 3 Gemcitabine 3 fludarabine phosphate 2 camrelizumab 2 apatinib 2 X-Rays 2 Riluzole 2 Radiotherapy 2 Photons 2 Magnetic Resonance Imaging 2 Lidocaine 2 Biopsy 2 zimberelimab 1 trastuzumab deruxtecan 1 tocilizumab 1 tislelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡